4 The Guideline Development Group, National Collaborating Centre and NICE project team, and declarations of interests

4 The Guideline Development Group, National Collaborating Centre and NICE project team, and declarations of interests

4.1 Guideline Development Group

The Guideline Development Group members listed are those for the 2015 update. For the composition of the previous Guideline Development Group, see the full guideline.

Jacqueline Berry
Lecturer/Practitioner in Diabetes Nursing, King's College Hospital and King's College London

Rudolf Bilous
Professor of Clinical Medicine, Newcastle University

Anne Dornhorst
Consultant Physician and Diabetologist, Hammersmith Hospital, London

Stacia Smales Hill
Patient and carer member

Aderonke Kuti
Patient and carer member

Michael Maresh
Consultant Obstetrician, St Mary's Hospital for Women, Manchester

Judy Shakespeare
GP, Cuttleslowe Surgery, Oxford

Katharine Stanley
Consultant Obstetrician and Gynaecologist, Norfolk and Norwich University Hospital

Elizabeth Stenhouse
Associate Professor Midwifery Research, Plymouth University

Diane Todd
Specialist Midwife for Diabetes, University Hospitals of Leicester

4.2 National Collaborating Centre for Women and Children's Health

David James
Clinical Director and Guideline Lead for Women and Children's Health (until November 2014)

Melanie Davies
Clinical Director for Women and Children's Health (from December 2014)

Shona Burman‑Roy
Senior Research Fellow

Paul Jacklin
Senior Research Fellow – Health Economist

Sarah Bailey
Research Associate (October 2013 until June 2014)

Anne Carty
Project Manager (from March 2014)

Cristina Visintin
Project Manager (November 2012 until March 2014)

Juliet Kenny
Project Manager (June 2011 until October 2012)

Nitara Prasannan
Research Associate (April 2012 until May 2013)

Ella Fields
Research Fellow (November 2012 until July 2013)

Rosalind Lai
Information Scientist (until October 2014)

Hugh McGuire
Senior Research Fellow (February 2012 until October 2012)

Moira Mugglestone
Director (September 2012 until April 2013)

Frauke Becker
Research Assistant – Health Economist (April 2013 until March 2014)

Omnia Abdulrazeg
Research Fellow (from July 2014)

4.3 NICE project team

Phil Alderson
Guideline Lead

Sharon Summers-Ma
Clinical Adviser

Sarah Dunsdon
Guideline Commissioning Manager (until May 2014)

Oliver Bailey
Guideline Commissioning Manager (from May 2014)

Besma Nash
Guideline Coordinator

Judith Thornton
Technical Lead

Bhash Naidoo
Health Economist

Lyn Knott
Editor

4.4 Declarations of interests

The following members of the Guideline Development Group made declarations of interests. All other members of the Group stated that they had no interests to declare.

Member

Interest declared

Type of interest

Decision taken

Jacqueline Berry

£100 towards Diabetes UK Conference fees for 1‑day admission to the conference from Novo Nordisk

Personal pecuniary

Declare and participate

Jacqueline Berry

Member of the Royal College of Nursing

Seconded to King's College London

Speaker at a Diabetes UK meeting (sensor‑augmented pump therapy in diabetes in pregnancy)

Spoke at SETDiG (South East London Diabetes Specialist Nurses) about practical management of diabetes in pregnancy. Did not receive payment or expenses

Personal non‑pecuniary

Declare and participate

Rudolf Bilous

Speaker fees from Boehringer Ingelheim, Novo Nordisk and Roche Diagnostics (no ongoing links with any of these companies in terms of topics covered by the guideline update)

Consultancy for Roche diagnostics and Roche Pharma (to advise on a peroxisome proliferator‑activated receptor (PPAR) alpha and gamma agonists for type 2 diabetes and renal disease)

Meeting expenses from Animas (insulin pumps), Boehringer Ingelheim, Johnson and Johnson (insulin pumps)

Invited to act as Principal Investigator on a study of a new insulin pump being developed by Roche

Honorarium and meeting expenses from the Cordelier Research Center (Paris)

Personal pecuniary

Declare and participate

Rudolf Bilous

Member of the MHRA Cardiovascular, Diabetes, Renal, Respiratory and Allergy Expert Advisory Group (CDDRAEG) of the Commission on Human Medicines and the MHRA Insulin Use group

GDG member for the National Kidney Foundation guideline on chronic kidney disease and diabetic kidney disease

Published research on diabetes and pregnancy based on the Northern Regional Diabetes Database of the Regional Maternity Survey Office (RMSO)

Member of data monitoring safety boards of the Adolescent type 1 Diabetes cardio‑renal Intervention Trial (AdDIT) and the atrasentan trial (not related to diabetes in pregnancy)

Personal non‑pecuniary

Declare and participate

Rudolf Bilous

Department receives funding from Diabetes UK

Department participates in a clinical trial on diabetes and hypertension through the Comprehensive Clinical Research Network (CCRN)

Non‑personal pecuniary

Declare and participate

Anne Dornhorst

Meeting expenses from Reata Pharmaceuticals (clinical trial of bardoxolone methyl; the meetings were also funded by Eli Lilly) and from European Association for the Study of Diabetes (EASD)

Personal pecuniary

Declare and participate

Anne Dornhorst

Seeking funding from Boehringer Ingelheim and Eli Lilly for a randomised controlled trial of asymptomatic hypoglycaemia in people with type 2 diabetes and chronic kidney disease using glicazide (a sulfonylurea) and linagliptin (a dipeptidyl peptidase‑4 (DPP4) inhibitor)

Honoraria for speaking about diabetic renal guidelines at North West Thames consultants and GPs meetings funded by Boehringer Ingelheim and Eli Lilly

Honorarium and expenses for speaking about diabetes in pregnancy at a diabetes symposium in Bristol funded by Novo Nordisk

Board member of the Novo Nordisk Foundation and the International Association of Diabetes and Pregnancy Study Groups (IADPSG)

Personal non‑pecuniary

Declare and participate

Anne Dornhorst

Husband is employed by Quintiles, which undertakes clinical trials for pharmaceutical companies (involves contact with scientific advisors at various companies)

Personal family

Declare and participate

Anne Dornhorst

Co‑applicant for funding from the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme for research relating to hyperglycaemia in pregnancy

Non‑personal pecuniary

Declare and participate

Michael Maresh

Speaker expenses from Diabetes UK; expenses to attend annual steering group re HAPO follow up study funded by NIH (US)

Personal pecuniary

Declare and participate

Michael Maresh

Department is funded by Diabetes UK to develop a test for fetal wellbeing in pregnancies complicated by type 1 diabetes (the test will not available before 2014)

Department funded by Bridges for an RCT using a DVD for women with gestational diabetes

Department funded by the National Institutes of Health (NIH), USA, for a follow‑up of women and children from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study

Co‑applicant for funding from the NIHR HTA programme for research relating to hyperglycaemia in pregnancy

Non‑personal pecuniary

Declare and participate

Michael Maresh

Spoke about non‑applicability of the World Health Organization diagnostic criteria for gestational diabetes, advantages of centralisation of care for type 1 diabetes, individualisation of decision making for timing and mode of birth, and results of the HAPO study

Paper accepted for publication on 'Stillbirth rates in pre‑gestational diabetic women' in Diabetic Medicine

Papers published on Timing of delivery and stillbirth rate in type 1 & 2 diabetes and Postnatal follow up of GDM – full GTT or fasting glucose

Paper published on Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes in Diabetes care

Is submitting a paper on Perinatal outcomes and glycaemic control in pregnancy

Personal non‑pecuniary

Declare and participate

Katharine Stanley

Honorarium and meeting expenses from Diabetes UK

Personal pecuniary

Declare and participate

Katharine Stanley

Department received a midwifery research grant from Novo Nordisk

Non‑personal pecuniary

Declare and participate

Elizabeth Stenhouse

Received payment for a manuscript in Practical Diabetes

Personal pecuniary

Declare and participate

Diane Todd

Member of the Diabetes UK conference organising committee, the NHS Diabetes Pregnancy Audit Group and Diabetes in Pregnancy Network Steering Group

Personal non‑pecuniary

Declare and participate

Diane Todd

Novo Nordisk paid registration fee for Diabetes UK annual professional conference 5–7 March 2014

Personal pecuniary

Declare and participate

  • National Institute for Health and Care Excellence (NICE)